Investigating the requirement of KRAS for the maintenance of pancreatic cancer

Investigating the requirement of KRAS for the maintenance of pancreatic cancer

Thesis: Ph. D., Massachusetts Institute of Technology, Department of Biology, 2016.

Bibliographic Details
Main Author:	Chen, Pan-Yu
Other Authors:	Tyler Jacks.
Format:	Thesis
Language:	eng
Published:	Massachusetts Institute of Technology 2016
Subjects:	Biology.
Online Access:	http://hdl.handle.net/1721.1/104173

Similar Items

Survival of pancreatic cancer cells lacking KRAS function
by: Noll, Elisa M., et al.
Published: (2017)

Adaptive and Reversible Resistance to Kras Inhibition in Pancreatic Cancer Cells
by: Chen, Pan-Yu, et al.
Published: (2020)

Identifying genes that are required for the maintenance of pancreatic ductal adenocarcinoma
by: Jenq, Harry
Published: (2013)

Whole body metabolic alterations as an early event in Kras-Driven cancers
by: Mayers, Jared Ross
Published: (2016)

Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
by: Sandy, Peter, et al.
Published: (2014)

More than just a KRAS inhibitor: DCAI abrogates the self-renewal of pancreatic cancer stem cells in vitro
by: Yuan, Han Teh, et al.
Published: (2023)

Study of hypoxia driven pancreatic cancer development
by: Gupta, Nikhil
Published: (2020)

A survey on the awareness of pancreatic cancer in singapore
by: Chong, Jasmine Jia Jun
Published: (2019)

Development and characterization of immunogenic genetically engineered mouse models of pancreatic cancer
by: Lambert, Laurens J.(Laurens Johannes)
Published: (2021)

Intercepting Pancreatic Cancer: Our Dream Teamʼs Resolve to Stop Pancreatic Cancer
by: Jacks, Tyler E
Published: (2020)

High-intensity focused ultrasound treatment for advanced pancreatic cancer
by: Zhou, Yufeng
Published: (2014)

PKM2 is not required for pancreatic ductal adenocarcinoma
by: Danai, Laura V, et al.
Published: (2018)

AGO2 in overexpression exhibits oncogenic functions KrasG̳1̳2̳D̳ -associated mouse tumor models
by: Thai, Kevin K. (Kevin Kinh)
Published: (2018)

Using Sequenom to identify KRAS mutations in an Asian cohort of ovarian mucinous cancer
by: Tiong, Wen Ning
Published: (2014)

Clonal dynamics following p53 loss of heterozygosity in Kras-driven cancers
by: Dorans, Kimberly, et al.
Published: (2017)

Investigation of the structure requirements for oligosaccharyl transferase function
by: Jaffee, Marcie B. (Marcie Beth)
Published: (2014)

Interleukin-6 Is Required for Pancreatic Cancer Progression by Promoting MAPK Signaling Activation and Oxidative Stress Resistance
by: Zhang, Yaqing, et al.
Published: (2013)

Expression of the Coxsackie and Adenovirus Receptor (CAR) in pancreatic cancer and normal pancreatic tissue
by: Verbeke, C. S., et al.
Published: (2006)

Personalized RNA Medicine for Pancreatic Cancer
by: Gilles, Maud-Emmanuelle, et al.
Published: (2020)

Keap1 loss promotes Kras-driven lung cancer and results in dependence on glutaminolysis
by: Sayin, Volkan I., et al.
Published: (2018)

Pancreatic macrophages: from ontogeny to phenotype and function
by: Ma, Ziyuan
Published: (2024)

ERO1α promotes hypoxic tumor progression and is associated with poor prognosis in pancreatic cancer
by: Gupta, Nikhil, et al.
Published: (2020)

Progressive Genomic Instability in the FVB/Kras[superscript LA2] Mouse Model of Lung Cancer
by: To, Minh D., et al.
Published: (2014)

Tissue of origin dictates branched-chain amino acid metabolism in mutant Kras-driven cancers
by: Ji, B. W., et al.
Published: (2018)

Characterization of the salivary microbiome in patients with pancreatic cancer
by: Torres, Pedro J., et al.
Published: (2016)

A Predictive Model for Pancreatic Cancer Diagnosis
by: Xiong, Thomas
Published: (2022)

Rationale design of pancreatic a-amylase inhibitor
by: Phua, Jeremy Joon How
Published: (2015)

STK33 kinase inhibitor BRD-8899 has no effect on KRAS-dependent cancer cell viability
by: Luo, Tuoping, et al.
Published: (2012)

Synthetic Lethal Interaction between Oncogenic KRAS Dependency and STK33 Suppression in Human Cancer Cells
by: Scholl, Claudia, et al.
Published: (2015)

Young capillary vessels rejuvenate aged pancreatic islets
by: Almaça, Joana, et al.
Published: (2015)

Differences in Nanoparticle Uptake in Transplanted and Autochthonous Models of Pancreatic Cancer
by: Tao, Zhimin, et al.
Published: (2022)

Differences in Nanoparticle Uptake in Transplanted and Autochthonous Models of Pancreatic Cancer
by: Tao, Zhimin, et al.
Published: (2021)

Pancreatic cancer treatment with targeted therapies: are we there yet
by: Nwaefulu, O. Ngozi, et al.
Published: (2022)

Pharmacological modulation of apoptosis and autophagy in pancreatic cancer treatment
by: Stanslas, Johnson, et al.
Published: (2022)

Mechanisms of oral bacterial virulence factors in pancreatic cancer
by: Sun, Zhong, et al.
Published: (2019)

Upholding a role for EMT in pancreatic cancer metastasis
by: Aiello, Nicole M., et al.
Published: (2018)

ADAM8 as a drug target in pancreatic cancer
by: Schlomann, Uwe, et al.
Published: (2017)

A subset of flavaglines inhibits KRAS nanoclustering and activation
by: Yurugi, Hajime, et al.
Published: (2021)

Investigating immune surveillance, tolerance, and therapy in cancer
by: Cheung, Ann F
Published: (2009)

Conditional knockout of N-WASP enhanced the formation of keratinizing squamous cell carcinoma induced by KRasG12D
by: Kalailingam, Pazhanichamy, et al.
Published: (2024)